Showing 64,421 - 64,440 results of 64,799 for search '(((( “cost OR “post) OR “most) in the shell” ) OR ( “host in the shell” ))~', query time: 0.53s Refine Results
  1. 64421
  2. 64422

    Chlorhexidine-alcohol versus Povidone-iodine plus Alcohol as Preoperative Antiseptic for Prevention of Surgical Site Infection in Caesarean Section: A Randomised Controlled Trial by Shravanthi Swamy, Aruna M Biradar, Ekta Chhabra, Shailaja Rajendra Bidri, Neelamma Patil, Shreedevi Kori, Shilpa Lakshmi, Preethi Malapure

    Published 2025-07-01
    “…Surgical Site Infection (SSI) remains a significant complication, impacting maternal recovery and healthcare costs. Aim: To evaluate the efficacy of chlorhexidine-alcohol versus Povidone-Iodine (PI) plus alcohol in preventing SSI in patients undergoing CS. …”
    Get full text
    Article
  3. 64423

    Hospital frailty risk score in predicting outcomes after simultaneous colon and liver resection for colorectal cancer liver metastasis in older adults: Evidence from the Nationwide... by Haohao Huang, Weidong Jin, Huiling Sun, Bo Diao, Ping Wang, Jiankun Jia, Dandan Ma, Yi Zhang

    Published 2025-08-01
    “…Frailty was significantly associated with increased risks of in-hospital mortality (adjusted odds ratio [aOR] = 3.65, 95% confidence interval [CI]: 2.52, 5.28), non-routine discharge (aOR = 2.44, 95% CI: 2.08, 2.87), prolonged LOS (aOR = 3.07, 95% CI: 2.60, 3.61), overall complications (aOR = 3.47, 95% CI: 3.03, 3.97), sepsis (aOR = 13.73, 95% CI: 9.76, 19.31), respiratory failure (aOR = 4.99, 95% CI: 3.80, 6.57), acute kidney injury (AKI) (aOR = 6.42, 95% CI: 4.83, 8.52), and acute liver failure (aOR = 2.10, 95% CI: 1.38, 3.21), as well as 32.69 thousand USD higher total hospital costs (95% CI: 28.41, 36.97) than no frailty. Incorporating frailty with traditional demographic and clinical risk factors improved in-hospital mortality prediction (area under ROC curve [AUC]: 0.765 to 0.799). …”
    Get full text
    Article
  4. 64424
  5. 64425

    Virtual Intervention for Vertebral frActures (VIVA): protocol for a feasibility study of a multicentre randomized controlled trial by Ada Sevinc, Alexandra Papaioannou, Suzanne N. Morin, Jennifer A. Watt, Raheem B. Kherani, Sheila Brien, Larry Funnell, Lehana Thabane, Lauren A. Beaupre, Jenna C. Gibbs, Heather Keller, Caitlin McArthur, Matteo Ponzano, Sonia Singh, Sharon Straus, Jenny Thain, Zachary J. Weston, Timothy H. Wideman, Christopher D. Witiw, Lora Giangregorio

    Published 2025-07-01
    “…The secondary outcomes include costs relative to benefit, effects on health-related outcomes (e.g. 30-s chair stand, Brief Pain Inventory, Quality of Life Questionnaire of the European Foundation for Osteoporosis-41, SCREEN-14), and outcomes related to implementation (e.g. participant and provider experience using semi-structured interviews, fidelity, number of screened and enrolled participants by referral source, fracture verification process). …”
    Get full text
    Article
  6. 64426

    Improving the accuracy of Respiratory Syncytial Virus (RSV) incidence estimates among hospitalised adults in Bristol, UK by Katie Lihou, Robert Challen, Anastasia Chatzilena, George Qian, Glenda Oben, Jade King, Serena McGuinness, Begonia Morales-Aza, Kaltun Duale, Ainhoa Rodriguez Pereira, William Healy, Jennifer Oliver, Nick Maskell, Adam Finn, Leon Danon, Catherine Hyams, Avon C. A. P. Research Group

    Published 2025-08-01
    “…The implementation of effective RSV vaccines could reduce morbidity, mortality and associated costs of disease. Adult RSV burden accuracy is improved by adjustment for test characteristics due to the impact of imperfect specificity when positivity-rates are low, and this is particularly important for out-of-season estimates. …”
    Get full text
    Article
  7. 64427

    Metabolic modulation to improve MSC expansion and therapeutic potential for articular cartilage repair by Ching Ann Tee, Daniel Ninio Roxby, Rashidah Othman, Vinitha Denslin, Kiesar Sideeq Bhat, Zheng Yang, Jongyoon Han, Lisa Tucker-Kellogg, Laurie A. Boyer

    Published 2024-09-01
    “…Currently, the only FDA cell-based therapy for articular cartilage injury is Autologous Chondrocyte Implantation (ACI); however, this procedure is costly, time-intensive, and requires multiple treatments. …”
    Get full text
    Article
  8. 64428

    Transient simulation of multi-product pipeline driven by flow mechanisms and operational data by Jian DU, Haochong LI, Qi LIAO, Kaikai LU, Jianqin ZHENG, Xiao YU

    Published 2024-10-01
    “…Most existing transient estimation methods rely on precise and reliable physical models, which involve high computational costs to address multi-condition and multi-parameter combinations. …”
    Get full text
    Article
  9. 64429

    Artificial Intelligence for Detecting COVID-19 With the Aid of Human Cough, Breathing and Speech Signals: Scoping Review by Mouzzam Husain, Andrew Simpkin, Claire Gibbons, Tanya Talkar, Daniel Low, Paolo Bonato, Satrajit S. Ghosh, Thomas Quatieri, Derek T. O'Keeffe

    Published 2022-01-01
    “…<italic>Goal:</italic> Official tests for COVID-19 are time consuming, costly, can produce high false negatives, use up vital chemicals and may violate social distancing laws. …”
    Get full text
    Article
  10. 64430

    A retrospective multi-site examination of chronic kidney disease using longitudinal laboratory results and metadata to identify clinical and financial risk by Mark Fung, Aya Haghamad, Elizabeth Montgomery, Kathleen Swanson, Myra L. Wilkerson, Kimon Stathakos, Richard VanNess, Sarah A. Nowak, Clayton Wilburn, Haluk Kavus, Mohammed Amer Swid, Nkemakonam Okoye, Yonah C. Ziemba, Girish Ramrattan, Jonathan Macy, John McConnell, Mary Jane Lewis, Beth Bailey, Khosrow Shotorbani, James M. Crawford

    Published 2024-12-01
    “…The imputed lost reimbursement under risk-adjusted payment systems for under-documentation of CKD in this subset of patients was $2.85 M for the three institutions combined, representing lost opportunity for both identification and proactive clinical management of these patients, and financial recovery for the costs of providing that care. Conclusions Clinical laboratories can provide value beyond routine diagnostics, helping to close gaps in care for identification and management of CKD, stratifying subgroups of patients to identify risk, and capturing missed reimbursement through risk adjustment factors.…”
    Get full text
    Article
  11. 64431
  12. 64432

    Protocol of a randomized, single-blind, controlled trial of an 18-month, home-based, high-intensity, exercise intervention in older, cognitively unimpaired APOE ε4 carriers by Stephen M. Rao, Alexandria L. Chorba, M. J. Helppi, Alina Tuladhar, Amanda L. Penko, Sarah Holley, Brandon Nehls, Sabrina Paulino, Matthew C. Streicher, Audrey Zhu, Kellie Bruening, Sally Durgerian, Katherine Koenig, Mark Lowe, Wanyong Shin, Stephen E. Jones, Rachel Galioto, Jagan A. Pillai, Lynn M. Bekris, James B. Leverenz, Anson B. Rosenfeldt, Tamanna Singh, Gerald J. Beck, J. Carson Smith, Jay Alberts, Jay Alberts

    Published 2025-05-01
    “…Secondary outcomes include comprehensive neurocognitive and physical function test batteries, MRI scans including structural and functional connectivity measures, and blood-based biomarkers.HypothesesOver an 18-month interval, physically inactive ε4 carriers who engage in high-intensity aerobic exercise will demonstrate less cognitive decline and hippocampal atrophy than physically inactive ε4 carriers who did not participate in a formal exercise program.ConclusionSuccessful demonstration of a scalable, home-based, high-intensity aerobic exercise intervention in altering the trajectory of AD pathophysiology and its effects on cognitive functioning will transform AD treatment, improve patient outcomes and quality of life, and reduce healthcare costs.…”
    Get full text
    Article
  13. 64433

    An explainable unsupervised learning approach for anomaly detection on corneal in vivo confocal microscopy images by Ningning Tang, Qi Chen, Yunyu Meng, Daizai Lei, Li Jiang, Yikun Qin, Xiaojia Huang, Fen Tang, Shanshan Huang, Qianqian Lan, Qi Chen, Lijie Huang, Rushi Lan, Xipeng Pan, Huadeng Wang, Fan Xu, Wenjing He

    Published 2025-06-01
    “…The proposed method enhances screening efficiency, reduces annotation costs, and holds great potential for scalable intelligent diagnosis of corneal diseases.…”
    Get full text
    Article
  14. 64434

    Preventing adverse events during paediatric cancer treatment: protocol for a multi-site hybrid randomised controlled trial of catheter lock solutions (the CLOCK trial) by Paul Monagle, Andrew Wood, Robert Ware, Adam Irwin, Joshua Byrnes, Natalie Bradford, Susan Moloney, Michelle Martin, Tricia Kleidon, Andrew Moore, Roni Cole, Fiona Newall, Victoria Gibson, Samantha Keogh, David Eisenstat, Amanda Ullman, Mari Takashima, Elouise Comber, Eloise Borello, Nicole Henson, Philippa Howard, Karen McCleary, Jordana McLean, Michelle Noyes, Gemma Rowan, Amanda St John, Joshua Wolf

    Published 2024-07-01
    “…Secondary outcomes will include CABSI, CVAD-associated-thrombosis, CVAD failure, incidental asymptomatic CVAD-associated-thrombosis, other adverse events, health-related quality of life, healthcare costs and mortality. To achieve 90% power (alpha=0.05) for the primary outcome, data from 720 recruitments are required. …”
    Get full text
    Article
  15. 64435
  16. 64436

    Assessment of bone mineral density in epileptic patients with long-term antiepileptic therapy: pilot data by N. A. Sivakova, I. V. Abramova, V. P. Rybasova, O. D. Bolshunova, E. D. Kasyanov, G. V. Rukavishnikov, M. A. Khobeysh, M. Yu. Sorokin, L. V. Lukina, N. I. Ananyeva, R. F. Nasyrova, V. A. Mikhailov, G. E. Mazo

    Published 2023-12-01
    “…The problem of decreased bone mineral density and frequent fractures in patients with epilepsy is an important and understudied issue that significantly reduces quality of life and involves significant economic costs for the treatment and rehabilitation of epileptic patients. …”
    Get full text
    Article
  17. 64437

    Critical care nurses’ knowledge regarding prevention of central venous catheter-related infection in Saudi Arabia: A cross-sectional study by Bassam Shyhan Alshammari, Salman Hamdan Alsaqri, Sameer A. Alkubati, Jordan H. Llego, Ahmad K. Al-Sadi, Aziza Z. Ali, Wessam A. Elsayed, Anas Mahmoud Balawi, Shaimaa Mohamed Nageeb, Laila A. Hamed

    Published 2025-04-01
    “…Background: Central venous catheter-related infections (CVC-RIs) are a significant concern in intensive care units (ICUs), contributing to increased morbidity, mortality, and healthcare costs. Nurses play a crucial role in preventing these infections through proper catheter care, adherence to aseptic techniques, and early detection of complications. …”
    Get full text
    Article
  18. 64438

    Delivering a national de-adoption programme: a documentary analysis of local commissioning policy compliance with England's Evidence-based Interventions programme (EBI) by Carmel Conefrey, Nicola Farrar, Maeve Coyle, Mike Bell, Jane Blazeby, Christopher Burton, Jenny Donovan, Andy Gibson, Joel Glynn, Tim Jones, Angus McNair, Josie Morley, Amanda Owen-Smith, Ellen Rule, Gail Thornton, Victoria Tucker, Iestyn Williams, William Hollingworth, Leila Rooshenas

    Published 2025-07-01
    “…Abstract Background In 2019 the English National Health Service (NHS) launched a national de-adoption programme to stop or limit access to surgical procedures considered to have little, or uncertain, evidence of benefit to justify their risks and/or costs: the Evidence-Based Interventions (EBI) programme. …”
    Get full text
    Article
  19. 64439

    Understanding the interests of academics from diverse disciplines to identify the prospective focus for a UK-based transdisciplinary network involving farm-to-fork stakeholders on... by K. Marie McIntyre, Maha Khan, Martha Betson, Lucy Brunton, Hernan Botero Degiovanni, Andrew P. Desbois, Mahmoud Eltholth, Paul Hurley, Lisa Morgans, John E. Pearl, Ruben Sakrabani, Orla Shortall, Katharina Watson, Jennifer Cole

    Published 2024-12-01
    “…This co-creation platform for network-wide systems-based activities would reduce inefficiencies in AMR-related activities around agrifood, providing a cross-cutting, cohesive community to deliver transformational guidance on relevant, practical agrifood solutions that add value by reducing AMR, antimicrobial usage and associated costs, and decreasing resultant environmental contamination by prioritising challenges, sharing knowledge and best practice, and co-creating practical solutions with key stakeholders. …”
    Get full text
    Article
  20. 64440